U.S. Markets closed

CombiMatrix Corporation (CBMX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.60+0.15 (+2.75%)
At close: 4:00PM EDT
People also watch
NANXACTGTINYFEICFLML

CombiMatrix Corporation

300 Goddard
Suite 100
Irvine, CA 92618
United States
949-753-0624
http://www.combimatrix.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees55

Key Executives

NameTitlePayExercisedAge
Mr. Mark D. McDonoughChief Exec. Officer, Pres and Director528.85kN/A48
Mr. Scott R. Burell CPAChief Financial Officer, Principal Accounting Officer, Treasurer and Sec.364.6kN/A52
Dr. Karine Hovanes Ph.D., FACMGVP of Scientific Advancement and Laboratory DirectorN/AN/AN/A
Dr. Michael P. Strathmann Ph.D.VP of R&DN/AN/AN/A
Mr. Marc W. BoothVP of EngineeringN/AN/A58
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CombiMatrix Corporation provides clinical molecular diagnostic laboratory services in the United States. The company focuses on pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It provides molecular diagnostic services primarily in the areas of reproductive health for the diagnosis of developmental disorders associated with intellectual disability, congenital anomalies, dysmorphic features, and autism spectrum disorders. The company’s testing focuses on advanced technologies, including single nucleotide polymorphism, chromosomal microarray analysis, sequencing, fluorescent in situ hybridization, and high resolution karyotyping. It serves commercial insurance companies, healthcare institutions, government payors, and individuals. CombiMatrix Corporation was founded in 1995 and is headquartered in Irvine, California.

Corporate Governance

CombiMatrix Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.